Clinical Trial Update: LAPAS Study: Insulin Glargine in Type 2 Diabetes Mellitus

View source ↗

Summary

Completed clinical trial (LAPAS) investigating insulin glargine in individuals with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED